Discontinued — last reported Q4 '24
Business Segments · Sales from commodity contracts (ASC 815)
Sugar and Bioenergy — Sales from commodity contracts (ASC 815)
Bunge Sugar and Bioenergy — Sales from commodity contracts (ASC 815) decreased by 100.0% to $0.00 in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $42.00M to $0.00. Over 3 years (FY 2021 to FY 2024), Sugar and Bioenergy — Sales from commodity contracts (ASC 815) shows a downward trend with a -21.9% CAGR.
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2024
How to read this metric
Fluctuations reflect changes in commodity market prices and the effectiveness of the segment's hedging strategies.
Detailed definition
Revenue recognized by the sugar and bioenergy segment specifically derived from commodity derivative contracts accounted...
Peer comparison
Common in commodity-heavy industries where derivative accounting is used to manage price exposure.
Metric ID:
bg_segment_sugar_and_bioenergy_sales_from_commodity_contracts_asc_815Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $66.00M | $66.00M | $66.00M | $63.25M | $63.25M | $63.25M | $63.25M | $64.00M | $70.00M | $53.00M | $42.00M | $42.00M | $48.00M | $36.00M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | -4.2% | +0.0% | +0.0% | +0.0% | +1.2% | +9.4% | -24.3% | -20.8% | +0.0% | +14.3% | -25.0% | -100.0% |
| YoY Change | — | — | — | — | -4.2% | -4.2% | -4.2% | +1.2% | +10.7% | -16.2% | -33.6% | -34.4% | -31.4% | -32.1% | -100.0% |
Range$0.00 – $70.00M
CAGR-100.0%
Avg YoY Growth-22.6%
Median YoY Growth-16.2%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bunge's sugar and bioenergy — sales from commodity contracts (asc 815)?
- Bunge (BG) reported sugar and bioenergy — sales from commodity contracts (asc 815) of $0.00 in Q4 2024.
- How has Bunge's sugar and bioenergy — sales from commodity contracts (asc 815) changed year-over-year?
- Bunge's sugar and bioenergy — sales from commodity contracts (asc 815) decreased by 100.0% year-over-year, from $42.00M to $0.00.
- What is the long-term trend for Bunge's sugar and bioenergy — sales from commodity contracts (asc 815)?
- Over 3 years (2021 to 2024), Bunge's sugar and bioenergy — sales from commodity contracts (asc 815) has grown at a -21.9% compound annual growth rate (CAGR), from $264.00M to $126.00M.
- What does sugar and bioenergy — sales from commodity contracts (asc 815) mean?
- Revenue generated from commodity derivative contracts used to manage price risk.